Praxis Precision Medicines (PRAX) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$3.36.
- Praxis Precision Medicines' EPS (Weighted Average and Diluted) fell 2218.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 3950.48%. This contributed to the annual value of -$11.18 for FY2024, which is 4019.18% up from last year.
- According to the latest figures from Q3 2025, Praxis Precision Medicines' EPS (Weighted Average and Diluted) is -$3.36, which was down 2218.18% from -$3.31 recorded in Q2 2025.
- Praxis Precision Medicines' 5-year EPS (Weighted Average and Diluted) high stood at -$0.96 for Q3 2022, and its period low was -$65.86 during Q4 2022.
- Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$2.84 (2024), whereas its average is -$7.54.
- Over the last 5 years, Praxis Precision Medicines' EPS (Weighted Average and Diluted) had its largest YoY gain of 9702.4% in 2023, and its largest YoY loss of 60066.23% in 2023.
- Praxis Precision Medicines' EPS (Weighted Average and Diluted) (Quarter) stood at -$65.86 in 2022, then surged by 97.02% to -$1.96 in 2023, then crashed by 82.22% to -$3.57 in 2024, then rose by 5.92% to -$3.36 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$3.36 for Q3 2025, versus -$3.31 for Q2 2025 and -$3.29 for Q1 2025.